We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.26T Turnover 23.45%
1-Year Est. Return 41.03%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+41.03%
3 Year Est. Return
+173.37%
5 Year Est. Return
+166.23%
10 Year Est. Return
+509.07%
AUM
$1.26T
AUM Growth
-$27.4B
Cap. Flow
-$3.98B
Cap. Flow %
-0.32%
Top 10 Hldgs %
26.48%
Holding
15,103
New
1,828
Increased
5,364
Reduced
6,090
Closed
1,713
Avg Time Held Equity + Options
3.9 years
Top 10 Avg Time Held Equity + Options
4.7 years
Top 20 Avg Time Held Equity + Options
5.5 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.6 years
Top 20 Avg Time Held Equity only
3.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.76%
2 Technology 2.14%
3 Communication Services 0.56%
4 Consumer Discretionary 0.56%
5 Healthcare 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DOUG icon
13001
CALL
Douglas Elliman
DOUG
$134M
$34.5K ﹤0.01%
22,700
+9,600
+73% +$17.3K
2026 Q2
1 quarter
MNY icon
13002
MoneyHero
MNY
$25.1M
$34.4K ﹤0.01%
49,108
-16,169
-25% -$14.2K
2025 Q3
4 quarters
KALA icon
13003
KALA BIO
KALA
$1.95M
$34.3K ﹤0.01%
+2,661
New +$62.7K
2026 Q3
0 quarters
VERI icon
13004
PUT
Veritone
VERI
$46.4M
$34K ﹤0.01%
28,600
-55,500
-66% -$61.1K
2023 Q1
14 quarters
ATCX icon
13005
Atlas Critical Minerals
ATCX
$6.91M
$33.8K ﹤0.01%
+11,258
New +$36.7K
2026 Q3
0 quarters
ASTI icon
13006
CALL
Ascent Solar Technologies
ASTI
$8.38M
$33.8K ﹤0.01%
+13,400
New +$43K
2026 Q3
0 quarters
INO icon
13007
Inovio Pharmaceuticals
INO
$320M
$33.6K ﹤0.01%
+27,502
New +$30.7K
2026 Q3
0 quarters
HTCR icon
13008
HeartCore Enterprises
HTCR
$2.47M
$33.5K ﹤0.01%
+16,849
New +$41.3K
2026 Q3
0 quarters
INV icon
13009
PUT
Innventure
INV
$14.4M
$33.5K ﹤0.01%
58,700
-114,000
-66% -$271K
2025 Q4
3 quarters
HEPS icon
13010
CALL
D-Market Electronic Services & Trading
HEPS
$1.12B
$33.5K ﹤0.01%
+13,600
New +$37.4K
2026 Q3
0 quarters
VENU icon
13011
Venu Holding
VENU
$58.3M
$33.1K ﹤0.01%
23,325
-6,945
-23% -$14.1K
2026 Q1
2 quarters
NMRA icon
13012
CALL
Neumora Therapeutics
NMRA
$65.5M
$32.9K ﹤0.01%
54,800
-34,700
-39% -$48K
2024 Q3
8 quarters
FABC icon
13013
Fabric.AI
FABC
$8.81M
$32.8K ﹤0.01%
+14,388
New +$37.5K
2026 Q3
0 quarters
AZTR icon
13014
Azitra
AZTR
$3.22M
$32.8K ﹤0.01%
23,825
+22,601
+1,846% +$34.1K
2026 Q2
1 quarter
CLPR icon
13015
PUT
Clipper Realty
CLPR
$47.7M
$32.8K ﹤0.01%
10,400
-9,600
-48% -$29.8K
2026 Q2
1 quarter
ELTX icon
13016
CALL
Elicio Therapeutics
ELTX
$42.5M
$32.8K ﹤0.01%
18,000
-163,400
-90% -$453K
2026 Q1
2 quarters
NVX icon
13017
CALL
NOVONIX
NVX
$47.4M
$32.8K ﹤0.01%
12,500
+9,780
+360% +$36.6K
2025 Q4
3 quarters
CDXS icon
13018
Codexis
CDXS
$115M
$32.7K ﹤0.01%
23,543
-58,980
-71% -$100K
2022 Q2
17 quarters
TNYA icon
13019
CALL
Tenaya Therapeutics
TNYA
$68M
$32.6K ﹤0.01%
54,300
-18,700
-26% -$13.6K
2025 Q3
4 quarters
CMRC icon
13020
CALL
Commerce.com Series 1
CMRC
$270M
$32.5K ﹤0.01%
10,300
-7,200
-41% -$20.5K
2025 Q1
6 quarters
MNOV icon
13021
MediciNova
MNOV
$65.1M
$32.3K ﹤0.01%
19,295
-7,457
-28% -$12.3K
2024 Q2
9 quarters
ARAY icon
13022
Accuray
ARAY
$6.36M
$32.3K ﹤0.01%
2,990
-17,650
-86% -$185K
2024 Q2
9 quarters
CHRS icon
13023
CALL
Coherus Oncology
CHRS
$59.8M
$32.2K ﹤0.01%
26,600
+14,000
+111% +$19.1K
2026 Q2
1 quarter
LASE icon
13024
PUT
LASE
LASE
$25.8M
$32K ﹤0.01%
37,700
-468,700
-93% -$534K
2025 Q2
5 quarters
USBC icon
13025
USBC
USBC
$122M
$31.9K ﹤0.01%
58,698
+44,825
+323% +$18.1K
2026 Q2
1 quarter

Similar funds

Jeff Yass's Q3 2026 Portfolio in Review

As of Q3 2026, Jeff Yass held 15,103 positions worth $1.26T, down 2.1% from $1.28T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q3 2026 filing shows 1,828 new, 5,364 increased, 6,090 reduced and 1,713 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M. The largest sale was Microsoft, an estimated $2.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q3 2026 buy was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $4.73B increase.
  • Jeff Yass's biggest Q3 2026 reduction was Microsoft, cutting an estimated $2.88B.
  • Jeff Yass fully exited Capital Group Growth ETF in Q3 2026, selling an estimated $279M.
  • Jeff Yass's ten largest holdings make up 26% of its $1.26T portfolio in Q3 2026.
  • Jeff Yass opened 1,828 new positions and closed 1,713 in Q3 2026.
  • Jeff Yass's portfolio value fell 2.1% quarter-over-quarter to $1.26T.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.